Voximetry provides personalized dosimetry services for radiopharmaceutical therapy (RPT), utilizing GPU-accelerated technology to analyze nuclear medicine scans and calculate patient-specific doses. This approach addresses the variability in treatment response among cancer patients, ensuring more accurate and effective therapy delivery without the need for in-house software deployment.
Funding
$4.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
NCFounders
Product
Problem
Response to radiopharmaceutical therapy (RPT) can vary significantly between patients, leading to inconsistent treatment outcomes when using standard-of-care approaches. Traditional dosimetry methods may not accurately account for individual patient physiology and tumor characteristics, potentially resulting in suboptimal dose delivery and increased toxicity.
Solution
Voximetry offers advanced dosimetry services for personalized RPT, leveraging GPU-accelerated technology to analyze nuclear medicine scans and calculate patient-specific doses. Their flagship product, Torch®, simplifies the complex task of assessing a patient’s scans to develop a personalized assessment, including estimates of patient-specific pharmacokinetics and calculation of dose to the tumors and critical structures. By providing dosimetry as a service, Voximetry helps clinicians maximize access to sophisticated patient-specific dosimetry while minimizing financial and technical risks, ultimately aiming to make routine dosimetry a reality for every RPT provider and patient worldwide. This approach enables more accurate and effective therapy delivery without the need for in-house software deployment and staffing.
Target Audience
Voximetry's primary customers include researchers, CROs, and clinicians involved in RPT who seek advanced dosimetry guidance without the burden of in-house software deployment and IT infrastructure.
Features
- GPU-accelerated processing of nuclear medicine scans for rapid dose calculations
- Patient-specific pharmacokinetic modeling to optimize treatment planning
- Advanced algorithms for calculating dose to tumors and critical structures
- Cloud-based service delivery, eliminating the need for on-site software installation and maintenance
- Compliance with dosimetry requirements for RPT clinical trials